Advertisement

Loading...

Grapefruit USA, Inc.

GPFT•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.001
$0.00(0.00%)
U.S. Market opens in 17h 26m

Grapefruit USA, Inc. (GPFT) Stock Overview

Explore Grapefruit USA, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap502.2K
P/E Ratio-0.79
EPS (TTM)$-0.01
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

GPFT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grapefruit USA, Inc. (GPFT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.79 and a market capitalization of 502.2K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-12.50%
5-Day Change
-12.50%
1-Month Change
40.00%
3-Month Change
14.19%
6-Month Change
40.00%
Year-to-Date (YTD) Change
6.06%
1-Year Change
40.00%
3-Year Change
-64.10%
5-Year Change
-99.53%
All-Time (Max) Change
-65.00%

Contact Information

https://www.grapefruitblvd.com
310 575 1175
1000 Northwest Street, Wilmington, DE, 19801

Company Facts

90 Employees
IPO DateJun 23, 2016
CountryUS
Actively Trading

Frequently Asked Questions